L3VLUP
ProSign in

BRKR · JNJ in the 13F filings

Two to four stocks side by side among the 95 tracked managers: who lists them, how that has moved, who bought and sold in a quarter, and which managers hold more than one.

BRKRJNJ
Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023

Holders over time

Tracked managers listing each stock every quarter, at least, or their combined reported value. A gap is a quarter in which no tracked manager listed it. Click a quarter to compare there.
  • BRKR
  • JNJ
0204060202120222023202420252026
Holders and value by quarter
QuarterBRKRJNJ
Q3 202010 holders, $2.2bn30 holders, $26.2bn
Q4 202010 holders, $3.0bn32 holders, $26.6bn
Q1 20218 holders, $3.6bn31 holders, $25.3bn
Q2 202114 holders, $4.3bn37 holders, $25.6bn
Q3 202118 holders, $4.2bn40 holders, $24.1bn
Q4 202115 holders, $4.1bn33 holders, $25.2bn
Q1 202213 holders, $3.0bn35 holders, $28.2bn
Q2 202214 holders, $2.9bn33 holders, $26.9bn
Q3 202214 holders, $1.7bn36 holders, $25.4bn
Q4 202210 holders, $2.0bn35 holders, $27.6bn
Q1 202312 holders, $2.1bn42 holders, $24.5bn
Q2 202312 holders, $2.0bn38 holders, $25.0bn
Q3 202311 holders, $1.4bn37 holders, $18.9bn
Q4 202313 holders, $1.7bn31 holders, $19.0bn
Q1 202410 holders, $2.1bn32 holders, $19.7bn
Q2 202410 holders, $1.7bn35 holders, $20.4bn
Q3 202410 holders, $1.8bn28 holders, $22.3bn
Q4 202412 holders, $1.4bn37 holders, $20.4bn
Q1 20259 holders, $817m32 holders, $20.5bn
Q2 20255 holders, $189m31 holders, $18.4bn
Q3 20257 holders, $123m32 holders, $23.7bn
Q4 20259 holders, $1.1bn29 holders, $27.8bn
Q1 20266 holders, $738m34 holders, $35.6bn
Q2 20269 holders, $1.8bn33 holders, $39.1bn
BRKR

Bruker Corp

Holders
9
Reported value
$817m
Buyers
3
Sellers
7

Breadth -4 among 95 comparable managers.

Medical devices and instrumentsHealthcare: biopharma and medtech · L3VLUP
JNJ

Johnson & Johnson

Holders
32
Reported value
$20.5bn
Buyers
16
Sellers
15

Breadth +1 among 95 comparable managers.

Pharmaceuticals and biotechnologyHealthcare: biopharma and medtech · L3VLUPPharmaceutical preparations

Who holds both, Q1 2025

Among the 35 tracked managers listing any of them. "Only" is about listed positions: a manager may hold the other below its listed range.

Only BRKR (3)

Farallon Capital Management LLC, Steadfast Capital Management LP, Two Sigma Investments LP

Only JNJ (26)

Acadian Asset Management LLC, Arrowstreet Capital LP, Balyasny Asset Management LLC, Brevan Howard Capital Management LP, Bridgewater Associates LP, Capital Research Global Investors, D. E. Shaw & Co., Dodge & Cox, Element Capital Management LLC, GAMCO Investors Inc, Hudson Bay Capital Management LP, Invesco Ltd, Man Group PLC, Markel Group Inc, Marshall Wace LLP, Millennium Management LLC, Neuberger Berman Group LLC, Renaissance Technologies LLC, Schonfeld Strategic Advisors LLC, Squarepoint Ops LLC, T. Rowe Price Associates Inc, Two Sigma Advisers LP, Verition Fund Management LLC, Wellington Management Group LLP, Winton Group Ltd, and 1 more

How much of the picture this is

A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. Buyers and sellers count comparable managers (those that filed both quarters) by shares, so a rise in value with no rise in shares is the price. Large books are listed to their largest positions. These are 95 tracked managers, not the institutional market.

Back to the 13F Explorer →